Haemophilus somnus activation of brain endothelial cells: Potential role for local cytokine production and thrombosis in central nervous system (CNS) infection

Summary

Thrombotic meningoencephalitis (TME) is a neurological condition in cattle characterized by fibrinopurulent meningitis with hemorrhage, abscess formation and thrombotic vasculitis throughout the central nervous system. The etiologic agent of TME is Haemophilus somnus, a gram-negative pleomorphic coccobacillus. Although the pathogenesis of TME is not well understood, the propensity of H. somnus to cause vasculitis and intravascular thrombosis suggests a critical role for the interactions between the bacteria and endothelial cells in inciting the disease. The goal of this study was to determine if H. somnus elicits an inflammatory and procoagulative response in bovine brain micro- vascular endothelial cells (BBEC) in vitro. We demonstrate that BBEC exposed to H. somnus secrete significant levels of the proinflammatory and procoagulative cytokines TNF-α and IL-1β. BBEC treated with H. somnus also display increased levels of IL-6 mRNA,another cytokine associated with coagulopathy in vivo. H. somnus-treated BBEC exhibited increased procoagulant activity and tissue factor expression and activity,along with a decreased ability to activate protein C and decreased expression of thrombomodulin mRNA. These changes would be expected to promote thrombus formation in vessels of the CNS, and potentially contribute to the pathogenesis of TME.

Keywords

Endothelial - infection - brain - thrombosis - Haemophilus

• References

• 1 Janzen FW. The Haemophilus somnus disease complex (hemophilosis): a review.. Can Vet J 1989; 30: 816-822.
• 2 Cines DB, Pollak ES, Buck CA. et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders.. Blood 1998; 91: 3527-3561.
• 3 Esmon CT. The interactions between inflammation and coagulation.. Br J Haematol 2005; 131: 417-430.
• 4 Myers DD, Wakefield TW. Inflammation-dependent thrombosis.. Front Biosci 2005; 10: 2750-2757.
• 5 Strukova S. Blood coagulation-dependent inflammation. Coagulation-dependent inflammation and inflammation- dependent thrombosis.. Front Biosci 2006; 11: 59-80.
• 6 Schnittler HJ, Preissner KT. Vascular endothelium and infectious diseases: trick and treat.. Thromb Haemost 2005; 94: 238-239.
• 7 Bielaszewska M, Karch H. Consequences of enterohaemorrhagic Escherichia coli infection for the vascular endothelium.. Thromb Haemost 2005; 94: 312-318.
• 8 Stins MF, Prasadarao NV, Zhou J. et al. Bovine brain microvascular endothelial cells transfected with SV40-large T antigen: development of an immortalized cell line to study pathophysiology of CNS disease.. In Vitro Cell Dev Biol Anim 1997; 33: 243-247.
• 9 Hezi-Yamit A, Wong PW, Bien-Ly N. et al. Synergistic induction of tissue factor by coagulation factor Xa and TNF: evidence for involvement of negative regulatory signaling cascades.. Proc Natl Acad Sci USA 2005; 102: 12077-12082.
• 10 Esmon CT. The impact of the inflammatory response on coagulation.. Thromb Res 2004; 114: 321-327.
• 11 Lopes-Bezerra LM, Filler SG. Endothelial cells, tissue factor and infectious diseases.. Braz J Med Biol Res 2003; 36: 987-991.
• 12 Shebuski RJ, Kilgore KS. Role of inflammatory mediators in thrombogenesis.. J Pharmacol Exp Ther 2002; 300: 729-735.
• 13 Bach RR. Tissue factor encryption.. Arterioscler Thromb Vasc Biol 2006; 26: 456-461.
• 14 Esmon CT. Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation.. Crit Care Med 2001; 29: S48-51 discussion 51–52.
• 15 Pathan N, Faust SN, Levin M. Pathophysiology of meningococcal meningitis and septicaemia.. Arch Dis Child 2003; 88: 601-607.
• 16 Brandtzaeg P, Bjerre A, Ovstebo R. et al. Neisseria meningitidis lipopolysaccharides in human pathology.. J Endotoxin Res 2001; 7: 401-420.
• 17 Heyderman RS, Klein NJ, Daramola OA. et al. Induction of human endothelial tissue factor expression by Neisseria meningitidis: the influence of bacterial killing and adherence to the endothelium.. Microb Pathog 1997; 22: 265-274.
• 18 Mirlashari MR, Hoiby EA, Holst J. et al. Outer membrane vesicles from Neisseria meningitidis: effects on tissue factor and plasminogen activator inhibitor- 2 production in human monocytes.. Thromb Res 2001; 102: 375-380.
• 19 Czuprynski CJ, Leite F, Sylte M. et al. Complexities of the pathogenesis of Mannheimia haemolytica and Haemophilus somnus infections: challenges and potential opportunities for prevention?. Anim Health Res Rev 2004; 5: 277-282.
• 20 Sylte MJ, Corbeil LB, Inzana TJ. et al. Haemophilus somnus induces apoptosis in bovine endothelial cells in vitro.. Infect Immun 2001; 69: 1650-1660.
• 21 Bombeli T, Karsan A, Tait JF. et al. Apoptotic vascular endothelial cells become procoagulant.. Blood 1997; 89: 2429-2442.
• 22 Kuckleburg CJ, Elswaifi SF, Inzana TJ. et al. Expression of phosphorylcholine by Histophilus somni induces bovine platelet aggregation.. Infect Immun 2007; 75: 1045-1049.
• 23 Thompson KG, Little PB. Effect of Haemophilus somnus on bovine endothelial cell in organ culture.. Am J Vet Res 1981; 42: 748-754.
• 24 Behling-Kelly E, McClenahan O, Kim KS. et al. Viable Haemophilus somnus induces myosin light-chain kinase-dependent decrease in brain endothelial monolayer resistance.. Infect Immun 2007; 75: 4572-4581.
• 25 Behling-Kelly E, Vonderheid H, Kim KS. et al. Roles of cellular activation and sulfated glycans in Haemophilus somnus adherence to bovine brain microvascular endothelial cells.. Infect Immun 2006; 74: 5311-5318.
• 26 Taha MK. Neisseria meningitidis induces the expression of the TNF-alpha gene in endothelial cells.. Cytokine 2000; 12: 21-25.
• 27 Verma S, Nakaoke R, Dohgu S. et al. Release of cytokines by brain endothelial cells: A polarized response to lipopolysaccharide.. Brain Behav Immun 2006; 20: 449-455.
• 28 Liu Y, Pelekanakis K, Woolkalis MJ. Thrombin and tumor necrosis factor alpha synergistically stimulate tissue factor expression in human endothelial cells: Regulation through c-Fos and c-Jun.. J Biol Chem 2004; 279: 36142-36147.
• 29 Nawroth PP, Handley DA, Esmon CT. et al. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity.. Proc Natl Acad Sci USA 1986; 83: 3460-3464.
• 30 Stern DM, Bank I, Nawroth PP. et al. Self-regulation of procoagulant events on the endothelial cell surface.. J Exp Med 1985; 162: 1223-1235.
• 31 Emerson Jr., TE, Lindsey DC, Jesmok GJ. et al. Efficacy of monoclonal antibody against tumor necrosis factor alpha in an endotoxemic baboon model.. Circ Shock 1992; 38: 75-84.
• 32 Szotowski B, Antoniak S, Poller W. et al. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines.. Circ Res 2005; 96: 1233-1239.
• 33 Wada H, Tanigawa M, Wakita Y. et al. Increased plasma level of interleukin-6 in disseminated intravascular coagulation.. Blood Coagul Fibrinolysis 1993; 4: 583-590.
• 34 van der Poll T, Levi M, Hack CE. et al. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees.. J Exp Med 1994; 179: 1253-1259.
• 35 Derhaschnig U, Bergmair D, Marsik C. et al. Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia.. Crit Care Med 2004; 32: 1136-1140.
• 36 Welty-Wolf KE, Carraway MS, Ortel TL. et al. Blockade of tissue factor-factor X binding attenuates sepsis-induced respiratory and renal failure.. Am J Physiol Lung Cell Mol Physiol 2006; 290: L21-31.
• 37 Carraway MS, Welty-Wolf KE, Miller DL. et al. Blockade of tissue factor: Treatment for organ injury in established sepsis.. Am J Respir Crit Care Med 2003; 167: 1200-1209.
• 38 Maris NA, de Vos AF, Bresser P. et al. Activation of coagulation and inhibition of fibrinolysis in the lung after inhalation of lipopolysaccharide by healthy volunteers.. Thromb Haemost 2005; 93: 1036-1040.
• 39 de Waard V, Hansen HR, Spronk HH. et al. Differential expression of tissue factor mRNA and protein expression in murine sepsis. The role of the granulocyte revisited.. Thromb Haemost 2006; 95: 348-353.
• 40 Carraway MS, Welty-Wolf KE, Miller DL. et al. Blockade of tissue factor: treatment for organ injury in established sepsis.. Am J Respir Crit Care Med 2003; 167: 1200-1209.
• 41 Creasey AA, Chang AC, Feigen L. et al. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.. J Clin Invest 1993; 91: 2850-2860.
• 42 Levi M, van der Poll T, ten Cate H. Tissue factor in infection and severe inflammation.. Semin Thromb Hemost 2006; 32: 33-39.
• 43 Henriksson CE, Hellum M, Landsverk KS. et al. Flow cytometry-sorted non-viable endotoxin-treated human monocytes are strongly procoagulant.. Thromb Haemost 2006; 96: 29-37.
• 44 Henriksson CE, Klingenberg O, Hellum M. et al. Calcium ionophore-induced de-encryption of tissue factor in monocytes is associated with extensive cell death.. Thromb Res 2007; 119: 621-630.
• 45 Henriksson CE, Klingenberg O, Ovstebo R. et al. Discrepancy between tissue factor activity and tissue factor expression in endotoxin-induced monocytes is associated with apoptosis and necrosis.. Thromb Haemost 2005; 94: 1236-1244.
• 46 Tiruppathi C, Naqvi T, Sandoval R. et al. Synergistic effects of tumor necrosis factor-{alpha} and thrombin in increasing endothelial permeability.. Am J Physiol Lung Cell Mol Physiol 2001; 281 (04) L958-968.
• 47 Esmon CT. The protein C pathway.. Chest 2003; 124: 26S-32.
• 48 Dhainaut JF, Yan SB, Margolis BD. et al. Drotrecogin alfa (activated) (recombinant human activated protein C) reduces host coagulopathy response in patients with severe sepsis.. Thromb Haemost 2003; 90: 642-653.
• 49 Lentz S, Tsiang M, Sadler J. Regulation of thrombomodulin by tumor necrosis factor-alpha: comparison of transcriptional and posttranscriptional mechanisms.. Blood 1991; 77: 542-550.
• 50 Moore KL, Esmon CT, Esmon NL. Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture.. Blood 1989; 73: 159-165.
• 51 Faust SN, Levin M, Harrison OB. et al. Dysfunction of endothelial protein C activation in severe meningococcal sepsis.. N Engl J Med 2001; 345: 408-416.